These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 16635306

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Management of combined hepatocellular and cholangiocarcinoma.
    Kassahun WT, Hauss J.
    Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
    [Abstract] [Full Text] [Related]

  • 23. Debating the presentation, morphology, origin, and prognosis of a combined hepatocellular-cholangiocarcinoma.
    Lorenzon L, Castaldo P, Bartolazzi A, Rossi Del Monte S, Camboni A, Pilozzi E, Salvi PF, Ziparo V.
    Dig Dis Sci; 2013 Aug; 58(8):2423-4. PubMed ID: 23695879
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Combined hepatocellular and cholangiocarcinoma].
    Omagari K, Makiyama K, Ikuno N.
    Ryoikibetsu Shokogun Shirizu; 1995 Aug; (7):473-5. PubMed ID: 8749529
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. MR imaging of the liver using gadolinium chelates.
    Low RN.
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):717-43, vi. PubMed ID: 11694435
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Wannhoff A, Hov JR, Folseraas T, Rupp C, Friedrich K, Anmarkrud JA, Weiss KH, Sauer P, Schirmacher P, Boberg KM, Stremmel W, Karlsen TH, Gotthardt DN.
    J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
    [Abstract] [Full Text] [Related]

  • 33. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
    Charatcharoenwitthaya P, Lindor KD.
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
    Chen CY, Shiesh SC, Tsao HC, Lin XZ.
    Hepatogastroenterology; 2002 Jan; 49(45):616-20. PubMed ID: 12063953
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Astronomically high CA 19-9 in a patient with a benign lesion.
    Rao NA, Satyaprakash BS.
    S Afr J Surg; 2013 Oct 29; 51(4):151. PubMed ID: 24209706
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.